NCT07499193

Brief Summary

The goal of this study is to better understand how eye blinking behavior is linked to the stability of the tear film, in adults aged 18 to 65 years, with or without symptoms of dry eye. The main questions are:

  • Do the results of a New Blink Task reflect tear film stability ?
  • How are the blink related metrics in relation with each other? Researchers will compare two groups of participants-those without dry eye symptoms and those with dry eye symptoms-to see if blinking measures differ between them and whether these measures relate differently to tear film quality. Participants will:
  • Answer a questionnaire about dry eye symptoms
  • Have their visual correction measured (if they wear glasses)
  • Undergo non-invasive assessments of tear film quality using an imaging device
  • Complete three types of blink tasks, each repeated three times, including measurements of blinking and of tear film stability

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Mar 2026Jun 2026

Study Start

First participant enrolled

March 1, 2026

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 17, 2026

Last Update Submit

March 23, 2026

Conditions

Keywords

dry eye

Outcome Measures

Primary Outcomes (1)

  • Evaluates the correlation between the Absolute Maximum Eye Aperture Duration measured in seconds and the non-invasive tear film break-up time measured in seconds measured with device IDRA .

    Day one

Secondary Outcomes (4)

  • Evaluates the correlation between the Absolute Maximum Eye Aperture Duration measured in seconds with parameters of dry eye ( tears meniscus height (mm), bulbar redness grade (from 0 to 4), blink quality (in %)) measured with device IDRA .

    Day one

  • Compares the coefficient of variation of the Absolute Maximum Eye Aperture Duration (in %) with the coefficient of variation of the non-invasive tear film break-up time (in %) measured with device IDRA .

    Day one

  • Evaluate the effects of ocular surface characteristics, demographics, and task acceptability on two primary outcomes via linear regression model

    Day one

  • Evaluate the effects of ocular surface characteristics, demographics, and task acceptability on coefficient of variation of two primary outcomes via linear regression model

    Day one

Study Arms (1)

Single arm

EXPERIMENTAL
Other: Blink behaviour

Interventions

Single intervention

Single arm

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteer, fluent in French, willing to follow the protocol, able to read and understand the information sheet and provide free and informed consent
  • Covered by a social security
  • Aged between 18 and 65 years inclusive
  • Binocular near visual acuity ≤ 0.3 LogMAR (≥ 5/10) (corrective glasses accepted)

You may not qualify if:

  • Employees of Essilor International, Luxottica, or GrandVision and their subsidiaries
  • Pregnant or breastfeeding women (Article L1121-5)
  • Individuals deprived of liberty by judicial or administrative decision, or hospitalized without consent under Articles L.3212-1 and L.3213-1, who do not fall under Article L.1121-8, and individuals admitted to a health or social care facility for purposes other than research
  • Adults unable or incapable of giving informed consent (Article L1121-8)
  • Participants deemed unfit to participate by the investigator for any reason that may affect subject safety or study integrity All categories of individuals particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the French Public Health Code).
  • Use of eye drops or ophthalmic solutions within the last 2 hours
  • Wearing contact lenses within the last 48 hours
  • Reported history of eye surgery or trauma to the eye or its adnexa excepted refractive surgery and cataract surgery
  • Reported history of eyelid abnormalities (ptosis)
  • Reported history of neurological deficits, including epilepsy or sensory-motor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders, nystagmus, Parkinson's disease)
  • Reported history of musculoskeletal disorders preventing maintenance of a fixed head position

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EssilorLuxottica - Neuroscience & Medical Research center

Paris, 94220, France

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Central Study Contacts

Sarah Marié, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2026

First Posted

March 30, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations